Reaction
Red Cell Distribution Width Decreased reporting signals
As of the last recalculation, Red Cell Distribution Width Decreased appears in 457 FAERS reports alongside 26 co-occurring drug terms. The strongest observed disproportionality signal is DIMENHYDRINATE (PRR 202.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Dimenhydrinate | 43 | 202.8 | 203.6 |
| Alemtuzumab | 63 | 171.9 | 172.5 |
| Diclofenac Potassium, Film Coated | 28 | 161.4 | 161.9 |
| Diclofenac Potassium Tablets | 28 | 161.3 | 161.8 |
| Diclofenac Potassium | 28 | 125.7 | 126.0 |
| Calcium Gluconate | 28 | 112.7 | 112.9 |
| Cortisone Acetate | 28 | 110.0 | 110.2 |
| Adalimumab-Fkjp | 86 | 103.9 | 104.1 |
| Adalimumab-Aaty | 86 | 101.7 | 101.9 |
| Cimetidine | 19 | 93.7 | 93.9 |
| Adalimumab-Adaz | 86 | 91.2 | 91.3 |
| Sulfasalazine | 103 | 77.1 | 77.2 |
| Desoximetasone | 25 | 63.2 | 63.2 |
| Leflunomide | 105 | 59.0 | 59.1 |
| Hydroxychloroquine Sulfate | 93 | 58.1 | 58.2 |
| Tocilizumab | 106 | 54.8 | 54.8 |
| Cetirizine Hydrochloride Allergy | 29 | 46.5 | 46.5 |
| Cetirizine Hydrochloride Tablets | 29 | 46.5 | 46.5 |
| Pseudoephedrine Hydrochloride | 10 | 45.3 | 45.3 |
| Abatacept | 104 | 44.0 | 44.0 |
| Pseudoephedrine Hcl | 10 | 42.2 | 42.3 |
| Diclofenac Sodium 1% | 28 | 38.0 | 38.0 |
| Diclofenac Sodium Topical | 28 | 38.0 | 38.0 |
| Diclofenac Sodium Topical Gel, 1% | 28 | 37.9 | 37.9 |
| Rucaparib | 4 | 20.8 | 20.8 |
| Emicizumab | 3 | 11.1 | 11.1 |